CI Medical Co (TSE:3540) Research & Development: 円0 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3540 CI Medical Co Ltd TSE:3540
70 GF Score
Price 円1,492.00
GF Value 円2,121.23
! 9 Warning Signs
View Full Analysis

What is CI Medical Co Research & Development?

CI Medical Co TSE:3540 70 Research & Development is 円0 Mil as of Jun. 2025. GuruFocus rates TSE:3540 with a GF Score™ of 70/100 and a GF Value™ of 円2,121.23. The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CI Medical Co's Research & Development for the six months ended in Jun. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was 円0 Mil.

CI Medical Co  (TSE:3540) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CI Medical Co Research & Development Related Terms

CI Medical Co Research & Development Historical Data

* Premium members only.

The historical data trend for CI Medical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CI Medical Co Research & Development Chart

CI Medical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CI Medical Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3540
70GF Score
CI Medical Co Ltd TSE:3540
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CI Medical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
CI Medical Co (TSE:3540) has a Research & Development of 円0 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on CI Medical Co and its competitors.
Is CI Medical Co's Research & Development too high?
CI Medical Co's current Research & Development is 円0 Mil. Overall, CI Medical Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does CI Medical Co's Research & Development compare to PG and CL?
CI Medical Co's Research & Development of 円0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CI Medical Co and its competitors. CI Medical Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CI Medical Co stock overvalued right now?
CI Medical Co (TSE:3540) has a current Research & Development of 円0 Mil. The stock's GF Value™ is 円2,121.23, compared to a current price of 円1,492.00 — trading 29.7% below its estimated fair value. The current Research & Development is 円0 Mil. CI Medical Co's overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CI Medical Co (TSE:3540), the current Research & Development is 円0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CI Medical Co (TSE:3540) Overvalued in 2026?

Based on GuruFocus' analysis, CI Medical Co stock appears to be undervalued. The current stock price of 円1,492.00 is trading 29.7% below its estimated GF Value™ of 円2,121.23.

Key valuation signals for TSE:3540:

  • Research & Development: 円0 Mil
  • GF Value™: 円2,121.23 vs. price of 円1,492.00 (29.7% below fair value)
  • GF Score™: 70/100 with 9 warning signs

No single metric tells the full story. See the TSE:3540 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CI Medical Co Business Description

Address 2-6 Asahigaoka, Hakusan, Ishikawa, JPN, 924-0004
CI Medical Co Ltd engages in the development, manufacturing, and sales of dental care products. It operates 3D design labs; it offers advertising and marketing services through its website "Dental Mall" and also manages oral health care website "Ci Mall" and "Dental Fit" through which it sells oral health products and dentures. It serves medical cooperatives, dental clinics, dental associations, health centers, dental colleges, veterinary clinics, nursing home care facilities, and dental dealers.
70GF Score

Get the complete analysis for TSE:3540

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,492.00
Price
円2,121.23
GF Value